Sen. Mitt Romney, U.S. Senator for Utah | Official U.S. Senate headshot
Sen. Mitt Romney, U.S. Senator for Utah | Official U.S. Senate headshot
WASHINGTON—U.S. Senator Mitt Romney (R-UT) took the lead in addressing concerns regarding the rescheduling of marijuana in a letter to the Drug Enforcement Administration (DEA) Administrator Anne Milgram. Alongside his colleagues, Ranking Member Jim Risch (R-ID) and Senator Pete Ricketts (R-NE), the senators emphasized the importance of compliance with U.S. treaty obligations under the Single Convention on Narcotic Drugs.
The senators stressed that any decision to reschedule marijuana should be based on factual evidence rather than policy preferences. They highlighted the necessity for the DEA to adhere to the Controlled Substances Act and ensure alignment with international treaty commitments.
Referring to the DEA's past determinations, the senators pointed out that classifying marijuana as a schedule I or II drug is crucial for upholding treaty obligations under the Single Convention. They underscored the significance of following the law and honoring the country's treaty commitments in such matters.
The letter addressed to Administrator Milgram outlined the senators' concerns and requested a response by a specified date. The senators expressed appreciation for the attention to the matter and anticipated a prompt reply from the DEA.
The discussion surrounding marijuana rescheduling and compliance with international treaties remains a topic of interest and importance for policymakers. The senators' letter serves as a reminder of the need for evidence-based decision-making in drug policy discussions.